Abstract |
The neurotrophin, brain-derived neurotrophic factor ( BDNF), characterises a probable neurobiochemical explanation of maldevelopments in schizophrenia and is a candidate biomarker of the illness. A paucity of studies examining neurobiochemical predictors of remission in schizophrenia exists. In this study, we seek to examine if serum BDNF level is associated with remission status in a sample of Chinese patients with schizophrenia. This study did not find a significant relationship between serum BDNF and remission in patients with schizophrenia. Identification of a suitable biomarker for diagnosis, management, and prognostic outcome is crucial and warrants further study.
|
Authors | Vidhya Renjan, Milawaty Nurjono, Jimmy Lee |
Journal | Psychiatry research
(Psychiatry Res)
Vol. 220
Issue 1-2
Pg. 193-6
(Dec 15 2014)
ISSN: 1872-7123 [Electronic] Ireland |
PMID | 25174850
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Biomarkers
- Brain-Derived Neurotrophic Factor
|
Topics |
- Adult
- Asian People
- Biomarkers
(blood)
- Brain-Derived Neurotrophic Factor
(blood)
- Female
- Humans
- Male
- Middle Aged
- Prognosis
- Schizophrenia
(blood, diagnosis)
- Severity of Illness Index
|